5-alpha reductase inhibitors use in prostatic disease and beyond (2023)
Bodie Chislett, David Chen, Marlon L. Perera, Eric Chung, Damien Bolton, Liang G. Qu
Abstract
5-alpha reductase inhibitors (5-ARIs) are commonly used and widely available, with benefits observed from their effect on...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.